
    
      The aim of this study is to analyze metabolomic profile of patients with cardiomyopathy in
      order to identify biochemical markers with risk stratification and prognostic value. Clinical
      data of enrolled patients regarding demographics, cardiovascular risk factorsï¼Œclinical lab
      data and previous cardiovascular disease will be recorded. Follow up will be at 3 months,6
      months,9 months,1 year and 3 years and will be performed by clinical recordings or phone call
      when necessary. Blood samples of patients with cardiomyopathy are taken when they enrolled.
      Serum samples will be analyzed by Liquid Chromatograph Mass Spectrometer/Mass Spectrometer.
    
  